• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The plasminogen activator system: biology and regulation.纤溶酶原激活物系统:生物学与调控
Cell Mol Life Sci. 1999 Oct 1;56(1-2):104-32. doi: 10.1007/pl00000615.
2
Post-transcriptional regulation of gene expression in the plasminogen activation system.纤溶酶原激活系统中基因表达的转录后调控。
Biol Chem. 2002 Jan;383(1):47-53. doi: 10.1515/BC.2002.005.
3
Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.早期胎盘形成过程中恒河猴妊娠子宫中尿激酶、纤溶酶原激活物抑制剂及尿激酶受体的表达
Placenta. 2000 Mar-Apr;21(2-3):184-93. doi: 10.1053/plac.1999.0446.
4
Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes.维甲酸上调人表皮角质形成细胞中的纤溶酶原激活物系统。
J Invest Dermatol. 2001 May;116(5):778-84. doi: 10.1046/j.1523-1747.2001.01310.x.
5
Diversity and modulation of plasminogen activator activity in human prostate carcinoma cell lines.人前列腺癌细胞系中纤溶酶原激活物活性的多样性与调节
Prostate. 1995 Oct;27(4):179-86. doi: 10.1002/pros.2990270402.
6
Regulation and interactions in the activation of cell-associated plasminogen.细胞相关纤溶酶原激活中的调节与相互作用。
Cell Mol Life Sci. 2004 Nov;61(22):2840-58. doi: 10.1007/s00018-004-4230-9.
7
Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo.大鼠前列腺癌细胞在体外产生纤溶酶原激活物和基质金属蛋白酶以及细胞外基质降解:与体内转移行为的相关性
Prostate. 1997 Aug 1;32(3):196-204. doi: 10.1002/(sici)1097-0045(19970801)32:3<196::aid-pros6>3.0.co;2-j.
8
The role of the urokinase-type plasminogen activator (uPA) and its receptor (CD87) in lipodermatosclerosis.
J Cutan Pathol. 2001 Jul;28(6):291-7. doi: 10.1034/j.1600-0560.2001.028006291.x.
9
Plasminogen activation in venous leg ulcers.
Br J Dermatol. 2000 Nov;143(5):930-6. doi: 10.1046/j.1365-2133.2000.03825.x.
10
Regulation and role of urokinase plasminogen activator in vascular remodelling.尿激酶型纤溶酶原激活剂在血管重塑中的调节作用
Clin Exp Pharmacol Physiol. 1996 Sep;23(9):759-65. doi: 10.1111/j.1440-1681.1996.tb01177.x.

引用本文的文献

1
Postoperative Adhesions: Current Research on Mechanisms, Therapeutics and Preventative Measures.术后粘连:关于机制、治疗方法及预防措施的当前研究
Biomed Mater Devices. 2025 Sep;3(2):897-937. doi: 10.1007/s44174-024-00236-7. Epub 2024 Sep 17.
2
Role of Clot Formation and Plasminogen Activation in Lower Urinary Tract Pathologies.血凝块形成和纤溶酶原激活在下尿路病理中的作用。
Arterioscler Thromb Vasc Biol. 2025 Jul 31. doi: 10.1161/ATVBAHA.125.321600.
3
Urokinase Plasminogen Activation System Modulation in Transformed Cell Lines.转化细胞系中尿激酶纤溶酶原激活系统的调节
Int J Mol Sci. 2025 Jan 15;26(2):675. doi: 10.3390/ijms26020675.
4
Connecting impaired fibrinolysis and dyslipidemia.连接纤溶功能受损与血脂异常。
Res Pract Thromb Haemost. 2024 Apr 5;8(3):102394. doi: 10.1016/j.rpth.2024.102394. eCollection 2024 Mar.
5
Compared to preoperative plasma levels post-operative urokinase-type plasminogen activator-1 levels are persistently elevated for 6 weeks after minimally invasive colorectal resection.与术前血浆水平相比,微创结直肠切除术后尿激酶型纤溶酶原激活物-1水平在6周内持续升高。
J Gastrointest Oncol. 2023 Feb 28;14(1):187-197. doi: 10.21037/jgo-22-113. Epub 2023 Feb 13.
6
Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).胰腺导管腺癌中的转移表型和免疫抑制肿瘤微环境:尿激酶型纤溶酶原激活物(PLAU)的关键作用。
Front Immunol. 2022 Dec 14;13:1060957. doi: 10.3389/fimmu.2022.1060957. eCollection 2022.
7
Changes in serum angiogenic factors among patients with acute pain and subacute pain.急性疼痛和亚急性疼痛患者血清血管生成因子的变化。
Front Mol Neurosci. 2022 Jul 15;15:960460. doi: 10.3389/fnmol.2022.960460. eCollection 2022.
8
TRPM7 restrains plasmin activity and promotes transforming growth factor-β1 signaling in primary human lung fibroblasts.瞬时受体电位阳离子通道亚家族 M 成员 7(TRPM7)抑制原代人肺成纤维细胞中的纤溶酶活性并促进转化生长因子-β1 信号通路。
Arch Toxicol. 2022 Oct;96(10):2767-2783. doi: 10.1007/s00204-022-03342-x. Epub 2022 Jul 21.
9
Role of Serine Proteases at the Tumor-Stroma Interface.丝氨酸蛋白酶在肿瘤-基质界面的作用。
Front Immunol. 2022 Feb 11;13:832418. doi: 10.3389/fimmu.2022.832418. eCollection 2022.
10
Prognostic Significance and Gene Co-Expression Network of and in Gliomas.胶质瘤中[具体基因名称]的预后意义及基因共表达网络
Front Oncol. 2022 Jan 11;11:602321. doi: 10.3389/fonc.2021.602321. eCollection 2021.

纤溶酶原激活物系统:生物学与调控

The plasminogen activator system: biology and regulation.

作者信息

Irigoyen J P, Muñoz-Cánoves P, Montero L, Koziczak M, Nagamine Y

机构信息

Friedrich Miescher Institute, Basel, Switzerland.

出版信息

Cell Mol Life Sci. 1999 Oct 1;56(1-2):104-32. doi: 10.1007/pl00000615.

DOI:10.1007/pl00000615
PMID:11213252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11146966/
Abstract

The regulation of plasminogen activation involves genes for two plasminogen activators (tissue type and urokinase type), two specific inhibitors (type 1 and type 2), and a membrane-anchored urokinase-type plasminogen-activator-specific receptor. This system plays an important role in various biological processes involving extracellular proteolysis. Recent studies have revealed that the system, through interplay with integrins and the extracellular matrix protein vitronectin, is also involved in the regulation of cell migration and proliferation in a manner independent of proteolytic activity. The genes are expressed in many different cell types and their expression is under the control of diverse extracellular signals. Gene expression reflects the levels of the corresponding mRNA, which should be the net result of synthesis and degradation. Thus, modulation of mRNA stability is an important factor in overall regulation. This review summarizes current understanding of the biology and regulation of genes involved in plasminogen activation at different levels.

摘要

纤溶酶原激活的调节涉及两种纤溶酶原激活剂(组织型和尿激酶型)、两种特异性抑制剂(1型和2型)以及一种膜锚定的尿激酶型纤溶酶原激活剂特异性受体的基因。该系统在涉及细胞外蛋白水解的各种生物学过程中发挥重要作用。最近的研究表明,该系统通过与整合素和细胞外基质蛋白玻连蛋白相互作用,还以独立于蛋白水解活性的方式参与细胞迁移和增殖的调节。这些基因在许多不同的细胞类型中表达,其表达受多种细胞外信号的控制。基因表达反映了相应mRNA的水平,而mRNA水平应该是合成和降解的净结果。因此,mRNA稳定性的调节是整体调节中的一个重要因素。本综述总结了目前对纤溶酶原激活相关基因在不同水平上的生物学和调节的理解。